4.7 Article

Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy

Gargi Kothari et al.

Summary: Radiomics has been used in prognostic modeling for non-small cell lung cancer, showing modest predictive capabilities with significant heterogeneity in methods. Future research should focus on standardized features, robust selection and development, and deep learning techniques to improve the models.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial

Corinne Faivre-Finn et al.

Summary: In the Phase 3, placebo-controlled PACIFIC trial, consolidative durvalumab after chemoradiotherapy showed significant improvements in overall survival and progression-free survival for patients with unresectable, stage III NSCLC, with consistent benefits observed approximately 4 years after treatment. Durvalumab demonstrated durable benefits with a higher 4-year survival rate and progression-free survival rate compared to placebo.

JOURNAL OF THORACIC ONCOLOGY (2021)

Article Statistics & Probability

The Blessings of Multiple Causes

Yixin Wang et al.

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2019)

Article Medicine, General & Internal

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S. J. Antonia et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Tracking the Evolution of Non-Small-Cell Lung Cancer

M. Jamal-Hanjani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Biology

Measurement bias and effect restoration in causal inference

Manabu Kuroki et al.

BIOMETRIKA (2014)

Article Mathematical & Computational Biology

Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values

Ian R. White et al.

STATISTICS IN MEDICINE (2010)

Article Oncology

Participation of patients 65 years of age or older in cancer clinical trials

JH Lewis et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

Article Statistics & Probability

Greedy function approximation: A gradient boosting machine

JH Friedman

ANNALS OF STATISTICS (2001)